MEI Pharma Inc (MEIP)
2.81
+0.01
(+0.36%)
USD |
NASDAQ |
Nov 21, 16:00
2.81
0.00 (0.00%)
Pre-Market: 20:00
MEI Pharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2021 | 95.01% |
| December 31, 2020 | 96.08% |
| September 30, 2020 | 92.33% |
| June 30, 2020 | 98.02% |
| March 31, 2020 | 30.87% |
| December 31, 2019 | 36.41% |
| September 30, 2019 | 40.54% |
| June 30, 2019 | 2.48% |
| March 31, 2019 | 6.89% |
| December 31, 2018 | 50.73% |
| Date | Value |
|---|---|
| September 30, 2018 | -102.7% |
| June 30, 2018 | -102.0% |
| March 31, 2018 | -114.8% |
| December 31, 2017 | -103.4% |
| September 30, 2017 | -118.4% |
| June 30, 2017 | -120.0% |
| March 31, 2017 | 74.54% |
| December 31, 2016 | 89.70% |
| September 30, 2016 | 0.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
30.87%
Minimum
Mar 2020
98.02%
Maximum
Jun 2020
74.79%
Average
93.67%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Avid Bioservices Inc | 14.22% |
| Evoke Pharma Inc | 96.08% |
| Revance Therapeutics Inc | 70.55% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |